Users of TRT [testosterone replacement therapy] had a 21 percent greater risk of cardiovascular events compared with nonusers, corresponding to an additional 128 events
Clinical studies have shown encouraging results, suggesting that Retatrutide could offer a new tool for those struggling with obesity, particularly when lifestyle interventions alone are insufficient
The primary difference lies in their mechanisms of action
When considering a GLP-1, its important to speak with your doctor face to face, Kadosh recommended
Variations of GLP-1 drugs have become massively popular in recent years as injectable weight-loss medication.
Lilly PACKAGE LABEL - Mounjaro Multi-Dose Vial - 2.5 mg/0.6 mL Dose (10 mg/2.4 mL [4.17 mg/mL]) Rx Only NDC 0002-4052-11 Mounjaro (tirzepatide) injection 10 mg/2.4 mL (4.17 mg/mL) ATTENTION: Contains 4 doses of 2.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient